- Home
- IPHA vs SPPP Comparison
IPHA vs SPPP Comparison
Compare IPHA & SPPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- SPPP
- Stock Information
- Founded
- IPHA 1999
- SPPP 2011
- Country
- IPHA France
- SPPP Canada
- Employees
- IPHA N/A
- SPPP N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- SPPP
- Sector
- IPHA Health Care
- SPPP
- Exchange
- IPHA Nasdaq
- SPPP NYSE
- Market Cap
- IPHA 160.1M
- SPPP 172.2M
- IPO Year
- IPHA 2019
- SPPP N/A
- Fundamental
- Price
- IPHA $1.74
- SPPP $12.63
- Analyst Decision
- IPHA Strong Buy
- SPPP
- Analyst Count
- IPHA 1
- SPPP 0
- Target Price
- IPHA $11.00
- SPPP N/A
- AVG Volume (30 Days)
- IPHA 11.2K
- SPPP 183.3K
- Earning Date
- IPHA 09-11-2025
- SPPP 01-01-0001
- Dividend Yield
- IPHA N/A
- SPPP N/A
- EPS Growth
- IPHA N/A
- SPPP N/A
- EPS
- IPHA N/A
- SPPP N/A
- Revenue
- IPHA $20,831,349.00
- SPPP N/A
- Revenue This Year
- IPHA $209.83
- SPPP N/A
- Revenue Next Year
- IPHA $83.15
- SPPP N/A
- P/E Ratio
- IPHA N/A
- SPPP N/A
- Revenue Growth
- IPHA N/A
- SPPP N/A
- 52 Week Low
- IPHA $1.29
- SPPP $8.55
- 52 Week High
- IPHA $3.51
- SPPP $11.39
- Technical
- Relative Strength Index (RSI)
- IPHA 42.70
- SPPP 68.78
- Support Level
- IPHA $1.71
- SPPP $11.57
- Resistance Level
- IPHA $1.90
- SPPP $11.96
- Average True Range (ATR)
- IPHA 0.08
- SPPP 0.25
- MACD
- IPHA 0.00
- SPPP -0.00
- Stochastic Oscillator
- IPHA 47.62
- SPPP 96.58
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.